Indian Journal of Clinical and Experimental Ophthalmology

Print ISSN: 2395-1443

Online ISSN: 2395-1451

CODEN : IJCEKF

Indian Journal of Clinical and Experimental Ophthalmology (IJCEO) is open access, a peer-reviewed medical journal, published quarterly, online, and in print, by the Innovative Education and Scientific Research Foundation (IESRF) since 2015. To fulfil our aim of rapid dissemination of knowledge, we publish articles ‘Ahead of Print’ on acceptance. In addition, the journal allows free access (Open Access) to its content, which is likely to attract more readers and citations of articles published in IJCEO. Manuscripts must be prepared in more...

  • Article highlights
  • Article tables
  • Article images

Article statistics

Viewed: 557

PDF Downloaded: 294


Get Permission Khurana and Sharma: Experimental models of Acanthamoeba keratitis


Introduction

Infectious keratitis is an inflammation of the cornea resulting from infections with bacteria, fungi, parasites, and viruses. It is a severe vision-impairing disease that severely affects the cornea, ultimately leading to perforation or scarring. It can be the result of direct invasion of the cornea by the pathogen or immunological damage to the cornea e.g. Lyme’s disease. Infectious keratitis is becoming quite common in humans mainly due to the excessive use of contact lenses and improper handling, corneal injury, and not practicing efficient hand hygiene.1 It has been estimated that globally more than 1.5 million people per year will develop blindness due to infectious corneal ulceration which is the fifth leading cause of blindness overall, responsible for up to 3.5% of all blind persons as of 2015.2 This burden is contributed maximally by low-income countries.3

Keratitis involves an interplay between the colonization of the infectious agent and the host’s response to it. This interaction of pathogen and host can be well understood in a living animal model or ex vivo. Cornea has a unique “immunologically privileged microenvironment” and these models have been proven to be useful to understand the mechanism of pathogenesis, disease biology, host immunity, and vaccination strategies, and provide an opportunity to develop diagnostic tests and an efficient keratitis treatment regime. However, successful establishment and standardization of the keratitis animal model largely depend on the animal chosen for the specific pathogen or the type of infectious agent. The most common infectious agents causing keratitis include bacteria like Staphylococcus aureus, Pseudomonas aeruginosa, and Streptococcus pneumoniae; fungi mainly Aspergillus, Fusarium and Candida spp; parasites especially Acanthamoeba spp; and viruses, especially herpes simplex virus & adenovirus. For Acanthamoeba keratitis (AK) contact lens wearing (improper handling of the contact lens and lens product) is the most frequently observed cause; however, several other risk factors like corneal abrasions with contaminated vegetable debris, refractive surgery, and penetrating keratoplasty.4, 5 This review will help provide an overview of the different experimental models including in vivo models, and ex vivo models for study of Acanthamoeba keratitis.

Acanthamoeba are free-living amoebae that are commonly found in the environment, particularly in water sources such as lakes, and rivers. The infection usually affects people who wear contact lenses, particularly those who use them improperly or do not practice good hygiene. It can also occur in people who have had corneal trauma. The symptoms of AK include severe eye pain, redness, blurred vision, sensitivity to light, and excessive tearing.6, 7 The infection can progress rapidly and can cause permanent damage to the cornea if left untreated.

Pathogenesis of Acanthamoeba Keratitis

The pathogenesis of AK involves several genes that are expressed by both the host and the organism. Some of the key genes involved in the pathogenesis of AK are:

  1. Cysteine protease (CP) genes: Acanthamoeba species express several cysteine proteases, which play a critical role in the invasion of the corneal epithelium. These proteases can degrade the extracellular matrix of the cornea, facilitating the penetration of the amoeba into the corneal tissue.8

  2. Mannose-binding protein (MBP) genes: Acanthamoeba species express MBPs, which bind to mannose-containing glycans on the surface of host cells, including the corneal epithelium. The interaction between MBPs and host cells can facilitate adherence and invasion of the amoeba into the corneal tissue.9, 10

  3. Matrix metalloproteinase genes: MMPs are enzymes that can degrade extracellular matrix components, including collagen and laminin. Acanthamoeba species express MMPs, which can contribute to the destruction of corneal tissue during infection.11

  4. Toll-like receptor (TLR) genes: TLRs are a family of pattern recognition receptors that play a critical role in the host immune response. Acanthamoeba species express lipopolysaccharide (LPS) and other pathogen-associated molecular patterns (PAMPs) that can activate TLRs and trigger an inflammatory response in the cornea.12

  5. Interleukin (IL) genes: ILs are cytokines that play a key role in the regulation of the immune response. During AK, the expression of various ILs is upregulated in the cornea, contributing to the inflammatory response and tissue damage.13

Overall, these genes along with other confounding factors contribute to the complex interplay between the host and the Acanthamoeba organism, which results in the development of AK. Understanding the exact role of these genes as well as other unexplored genes in the pathogenesis of AK could lead to the development of new therapies for this serious infection.14, 15, 16, 17

Experimental Models available for Acanthamoeba Keratitis

Experimental models play a crucial role in advancing our knowledge of Acanthamoeba keratitis by providing a controlled and reproducible platform for investigation. These models, which can be both in vivo and ex vivo, allow researchers to study various aspects including host-parasite interaction, pathogenesis, and immune response. This review will explore the different experimental models available for the AK. By examining the strengths and limitations of each model, and considering factors such as reproducibility, ethical considerations, physiological relevance, and translational potential, we can gain a comprehensive understanding of their utility in advancing our knowledge of AK.

In vivo models

In vivo, models are best used to study the salient features of keratitis and pathogenicity inflicted by both the infectious agent and the host immune response. While the most common animal model is the mouse, other animals like rats, rabbits and hamsters have also been used. While establishing keratitis in the animal model, different routes of inoculating the organism are used that allow for direct exposure of the organism to the cornea and the establishment of infection (Figure 1).

  1. Contact lens-mediated infection: Contact lens-mediated inoculation is a widely used method for establishing AK in animal models.9, 10, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41 This technique involves placing a contact lens on the cornea and introducing Acanthamoeba onto the surface of the contact lens, allowing more time for the organism to adhere to the cornea and initiate infection. However, special contact lenses are to be manufactured (which are quite expensive) to fit the mouse cornea which is small and has an acutely steep curvature. To overcome this issue, we have recently suggested the use of Parafilm as a convenient, cheaper and reliable alternative to contact lenses.21Some of the advantages of using contact lens-mediated inoculation for AK in animal models are:

    1. Mimics human infection: Acanthamoeba keratitis in a human occurs in contact lens wearers due to the presence of the organism on contaminated lenses. The use of contact lens-mediated inoculation is one of the best ways to replicate the natural route of infection and closely mimic the conditions that lead to AK in humans.

    2. Controlled infection duration: With this method, the contact lens can be worn for a specific duration, allowing researchers to control the length of exposure to Acanthamoeba. This is particularly useful when investigating the different stages of infection or evaluating the effectiveness of interventions at various time points.

    3. Enhanced adherence of Acanthamoeba: Acanthamoeba has a propensity to adhere to the surface of the contact lens surface, making this method particularly effective for establishing infection. The contact lens provides a surface for Acanthamoeba to attach to, increasing the likelihood of successful colonization and subsequent infection.

    4. Reproducibility: Contact lens-mediated inoculation offers high reproducibility, allowing consistent and standardized infection models. The inoculum size and contact lens parameters, such as material and fit, can be carefully controlled, resulting in reliable and comparable outcomes across different experiments.

    5. Non-invasive technique: In comparison to invasive methods like intrastromal injections, contact lens-mediated inoculation is less invasive and causes minimal trauma to the cornea. This is beneficial for minimizing tissue damage, maintaining ocular integrity, and reducing potential confounding factors associated with more invasive procedures.

  2. Intrastromal injection: In this method, a small amount of the inoculum is injected directly into the corneal stroma, using a fine needle. The procedure involves first creating a tunnel through the epithelium with a 30G needle, and then delivering the inoculum directly into the underlying stroma using a 33G Hamilton syringe that has been placed into the tunnel. This method ensures that a specific number of organisms are delivered directly into the stroma and remain confined within the stroma. However, a major limitation of this method is the thin corneal thickness of the mouse which becomes the leading cause of corneal perforation in up to 15% of cases. This method is commonly used to establish bacterial, fungal, viral or parasitic keratitis.22, 24, 37, 38, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62

  3. Scratch injury: This method involved creating a small scratch or abrasion on the surface of the cornea, followed by placing the inoculum on the scratched area. The method of scratch injury and topical inoculation aims to introduce the infectious organism onto the cornea to initiate the infection process. The specific details of the corneal scratch and topical inoculation methods can vary depending on the infectious organism being studied, the desired severity of keratitis, and the specific experimental protocol. This method offers several advantages for inducing keratitis in animal models:

    1. Stimulates natural infection: By directly introducing the infectious organism onto the cornea, these methods closely mimic the natural route of infection that occurs in human keratitis. This in turn helps to study the disease progression, host-pathogen interactions, and immune responses in a manner that closely resembles the clinical scenario.

    2. Reproducibility: This method provides a high level of reproducibility as they allow for precise and consistent delivery of the infectious organism onto the cornea. This is essential for conducting experiments with multiple animals and comparing results across different studies.

    3. Reduced invasiveness: Compared to more invasive methods, such as intrastromal injections or subconjunctival injections, corneal scratch and topical inoculation are relatively less invasive. This helps minimize the potential for tissue damage and adverse effects associated with the procedure itself.

  4. Subconjunctival injection: In this method, the organism is injected under the conjunctiva, the thin membrane that covers the white part of the eye and lines inside the eyelids. This method ensures that the organism is introduced close to the cornea, facilitating its migration and subsequent infection. The route of subconjunctival injection aids in the establishment of infection by providing the opportunity for Acanthamoeba to infiltrate the corneal tissue. These methods may be modified or combined depending on the specific organism being studied and the desired outcome of the experiment.37

These methods typically involve less discomfort and trauma for the animals compared to more invasive techniques. This aligns with the principles of animal welfare and reduces the potential for unnecessary suffering during the experimental process.

Overall, corneal scratch and topical inoculation methods offer researchers the ability to establish keratitis in animal models in a controlled and reproducible manner, facilitating investigations into the pathogenesis, immunology, and therapeutic interventions for this ocular disease.

Figure 1

Schematic depiction of the different inoculation methods for inducing Acanthamoeba keratitis

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/46b50b0b-139c-4469-9506-06e9cca4fd83image1.png

Mice

Mice have been used for the development of various keratitis models using different modes and methods of application of the pathogen. There are numerous strains of inbred and outbred mice, genetically modified mice and a wide array of mouse-specific reagents available for experimental work. The most widely used inbred mouse strains are BALB/c and C57BL/6, and several distinctions between these backgrounds should be taken into account when designing an experiment. Some mouse strains are more likely than others to experience ocular irritation. For instance, IL-12-mediated corneal damage affects Th1-responder strains like C57BL/6N, but Th2 responders like BALB/c mice exhibit IL-18-mediated less corneal infrastructure destruction. As with age, experimental keratitis models have been employed with both younger (weeks dimensions) and older (months dimensions) mice.63, 64, 65, 66, 67, 68, 69 Beyond those factors, the technology used, the choice of the pathogen, and its emphasis on infection are crucial. Unlike bacterial and fungal keratitis, very few studies are reported that have employed mice for the establishment of amoebic keratitis. Ren and Wu produced Acanthamoeba keratitis in rats and mice for comparing the advantages of three different modes of inoculation, namely, the use of intrastromal injection, the use of contact lens, and topical application of parasitic suspension, post-corneal debridement. 25 Corneal scarring alone has the lowest infection rate while scratching and then covering with contaminated contact lenses has a moderate rate of infection.20, 24 Reports suggest the use of contact lenses prepared from filter paper and parafilm as an alternative to conventional contact lenses for establishing Acanthamoeba keratitis in mice.21, 23 Additionally, the Acanthamoeba keratitis in a C57BL/6 mouse model helped elucidate that IL-17A production plays a vital role in host protection against invading parasites.22

Rat

The use of a mouse in the establishment of the keratitis model has one major shortcoming of the tiny eye size. The majority of studies on the standardization of the Acanthamoeba keratitis model has mainly employed the use of Wistar rats in comparison to the use of mouse and has used the technique of abrasing the cornea before the intrastromal inoculation of Acanthamoeba trophozoites.44, 46, 49, 51 Though intrasomal inoculation has a higher chance of establishing keratitis, however, has the drawback that it does not mimic the natural route of Acanthamoeba infection in humans, which is generally through a contact lens. 70 There are several reports related to the induction of AK in rats using the intrastromal route of Acanthamoeba inoculation. The role of TLR-4 has been investigated in Wistar rats during Acanthamoeba infection and TLR-2 and TLR-4 were found upregulated during Acanthamoeba infection, thereby providing a better insight into the mechanism of innate immunity. 48 Furthermore, compounds and drugs such as Propolis, Polyhexamethylene biguanide, Chlorhexidine gluconate, Neosporin, Miltefosine, and Voriconazole have been tested for their anti-Acanthamoeba activity in the rat keratitis model.43, 45, 47, 50 Another study by Zorzi et al. comprised Box Behnken design of siRNA-loaded liposomes which were used to treat Acanthamoeba keratitis in a murine model. The only treatment regime led to a 60% reversal of keratitis-associated corneal damage, demonstrating an integral epithelium without lymphocytic infiltrate.61

Rabbit

Rabbits are extensively used in keratitis models as they are relatively a preferable choice because their cornea resembles more like that of humans in comparison to those of other animals; they have big eyes, and the disease score can be given to a maximum of 28 in contrast to mice where the lesions can be scored to a value of 4 only.57

Few studies are reported in the past related to the development of AK in a rabbit model. Acanthamoeba keratitis was established in New Zealand white rabbits using intra-stromal injection and micro-injection of Acanthamoeba trophozoites to portray a natural mode of infection, unlike the one set by using an infected contact lens.57 The authors suggest this alternate mode as Acanthamoeba keratitis has also been reported in non-contact lens wearers due to some corneal injury or cataract surgery. Thus, they have attempted to establish keratitis by microinjection of Acanthamoeba trophozoites in the anterior part of the corneal stroma. Another study has established Acanthamoeba keratitis by employing a contact lens with a modification of cornea debridement using a sharp diamond burr instead of a syringe needle or surgical blade.40 A group led by Nakagawa has demonstrated that bacteria might be contributing factors in the development of Acanthamoeba keratitis. Their subsequent experiments suggest that a certain number of bacteria are a critical requirement for the successful establishment of Acanthamoeba keratitis.56, 58 The inoculation of rabbit cornea with Acanthamoeba plus high P. aeruginosa treated immediately with levofloxacin, and betamethasone sodium phosphate demonstrated AK infection. This confirmed the capability of topical corticosteroids in aggravating Acanthamoeba keratitis infection.55 There are reports of treating fungal keratitis with corneal cross-linking (CXL); however, (CXL; riboflavin/ultraviolet A) was found ineffective in decreasing the intensity and severity of Acanthamoeba keratitis.59 In contrast, rose bengal (RB) mediated photodynamic antimicrobial therapy (PDAT) and cationic chlorin derivative photosensitizer) ‐ mediated photodynamic antimicrobial chemotherapy (PACT) was found to be effective against the Acanthamoeba keratitis rabbit model.38, 39

Hamster

The results from various experiments on different vertebrate animals have suggested hamsters as potent candidates for multiple procedures. The keratitis studies on hamsters have either used the contact lens laden with a pathogen or employed intra-stromal inoculations. Research in the past has suggested the cornea of hamsters is quite susceptible to Acanthamoeba infection based on in vitro results.71 Studies led by Hurt et al. and others have established Acanthamoeba keratitis in hamsters using contact lenses laden with trophozoites on the cornea that has been abraded.30 Another study demonstrated that Acanthamoeba keratitis is significantly affected by mannosylated proteins present on the ocular surface, which activate amoeba to produce pathogenic protease. This 133 kDa protease, in turn, led to the degradation of corneal epithelium and increased disease severity. Oral immunization of Chinese hamsters with recombinant mannose-binding protein was confirmed by the presence of anti-MBP in the tear fluid of immunized animals.10 Another group led by Tripathi et al., 2013 elucidated that cytosolic phospholipase (cPLA2α) is involved in MIP-133-induced apoptosis of corneal epithelial cells and targeting cPLA2α through inhibitors can be used as a therapeutic target in Acanthamoeba keratitis.26

Additionally, Acanthamoeba keratitis in hamsters to study the role of macrophages and neutrophils in the disease was also attempted. Inhibition of neutrophil migration by injecting an antibody against macrophage inflammatory protein 2 (MIP-2) resulted in increased disease severity. Neutrophils play an essential role in fighting against Acanthamoeba infections in the cornea.28, 31 The intra-corneal injection of latex beads demonstrated resistance to Acanthamoeba keratitis, most likely mediated by macrophages. Furthermore, the treatment of macrophages with the macrophagicidal drug clodronate eliminated the latex beads’ protective effect.29

The Acanthamoeba infection is exacerbated under the influence of steroid treatment usually prescribed for corneal inflammation, administered after surgery, or to prevent corneal graft rejection. McClellan et al. have suggested effective amoebicidal therapy while taking topical steroidal treatment for Acanthamoeba.32 The role of TLR-4 in disease pathogenesis and a potential drug target for devising better treatment options for Acanthamoeba infections has been explored previously.25 Alexedine and miltefosine have shown effective results against Acanthamoeba keratitis.47, 72 However, the assessment of riboflavin and UV-A light treatment against Acanthamoeba did not demonstrate any anti-trophozoite activity.27

Other animals

The Acanthamoeba keratitis model has been established maximally in mice, rats, rabbits and hamsters. A group led by He et al. had successfully developed the Acanthamoeba keratitis model in Yucatan micropigs using the route of parasite-laden contact lenses. They suggested a strong correlation between the clinical and histopathologic features of contact lens-induced AK in pigs as well as the anatomical similarity of the pig eye to the human eye.41

Ex vivo AK model

To study AK ex vivo, which means outside of a living organism, researchers typically use cell culture techniques. Cell culture models involve growing cells from the cornea, which is the outermost layer of the eye, in a laboratory dish and exposing them to Acanthamoeba. This can be useful for understanding the basic biology of the interaction between the amoeba and the cornea cells, but it may not completely replicate the complex environment of the eye. The potential of Acanthamoeba castellani to adhere, permeate, and damage healthy, intact corneas of 11 mammalian and one avian species was examined in a series of in vitro investigations. It was observed that the parasite failed to produce any significant cytopathic effects on mice, rats, cotton rats, horses, guinea pigs, cows, chickens, dogs, and rabbits. However, during the 24-hour in vitro incubation phase, parasites attached, penetrated, and severely damaged the corneas of humans, pigs, and Chinese hamsters. The findings show that A. castellani exhibits strict host specificity at the surface of the host cell.71 The ex vivo models have a set of advantages and limitations, and researchers often use a combination of approaches to better understand the biology of Acanthamoeba and develop new treatment options.

Limitations of Animal Models

Animals have been the most frequently used models to study diseases of humans including keratitis. However, there are some characteristics which are uniquely different in the human eye compared to animals. The human cornea is about 11.5 mm in diameter while that of rabbits and mice have corneas of 13 and 2.5-3.5mm respectively. Humans have thicker corneas than rabbits and mice, and their blink intervals are about 2.8 seconds compared to nearly 30 seconds for both of the other species.70, 73, 74 The composition of lacrimal gland secretions is also different with an abundance of lysozyme in human secretions. These factors affect the adherence and invasion properties of pathogens and also the host defence. Despite various contrasting characteristics between humans and animals that primarily affect the results obtained from animal models, animals have conferred the basic understanding of disease pathogenesis, and pathology, and finding drugs and compounds effective against infectious keratitis.75, 76, 77, 78, 79, 80

  1. Species differences: Animals used in keratitis models may exhibit variations in ocular anatomy, physiology, and immune responses compared to humans. These differences can influence the course and characteristics of the disease, potentially limiting the direct applicability of findings to human keratitis.

  2. Lack of host immune system diversity: Animal models often involve studying keratitis in a specific strain or species of animals with limited genetic diversity. This can restrict the ability to capture the full spectrum of host immune responses and disease outcomes observed in humans.

  3. Artificial inoculation methods: The methods used to establish keratitis in animal models, such as corneal scratch, topical inoculation, or subconjunctival injection, involve artificial means of introducing the infectious organism. These methods may not fully replicate the natural infection route and dynamics observed in human keratitis.

  4. Shorter disease course: The natural course of keratitis in animals may differ from the typically longer duration and chronic nature of keratitis in humans. The shorter disease course in animal models can affect the understanding of disease progression, chronicity, and long-term outcomes.

Conclusion

In conclusion, animal models have proven to be invaluable in providing insights into the pathogenesis, host immune response, and treatment strategies for Acanthamoeba keratitis. Although animal models have provided significant contributions to our understanding of AK, it is important to acknowledge their limitations. Animal models do not fully replicate the complexity of the human eye and the host immune response. Furthermore, there can be variations in the response to infection among different animal species, which may limit the generalizations of the findings. These models have provided a platform for further research, enabling the development of improved diagnostic techniques, therapeutic interventions, and preventive measures to combat this sight-threatening disease.

Source of Funding

Not applicable.

Conflict of Interest

There is no conflict of interest

Acknowledgement

Not applicable.

References

1 

S Khurana M Sharma Parasitic keratitis-An under-reported entityTrop Parasitol2020101127

2 

JP Whitcher M Srinivasan MP Upadhyay Corneal blindness: a global perspectiveBull World Health Organ200179321421

3 

SR Flaxman RRA Bourne S Resnikoff P Ackland T Braithwaite MV Cicinelli Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysisLancet Glob Health20171212122134

4 

M Cabrera-Aguas P Khoo SL Watson Infectious keratitis: A reviewClin Exp Ophthalmol202250554362

5 

U Gopinathan S Sharma P Garg GN Rao Review of epidemiological features, microbiological diagnosis and treatment outcome of microbial keratitis: experience of over a decadeIndian J Ophthalmol20095742739

6 

ST Awwad WM Petroll JP Mcculley HD Cavanagh Updates in Acanthamoeba keratitisEye Contact Lens200733118

7 

J Walochnik Twenty‐five years of acanthamoeba diagnostics in AustriaActa Ophthalmol202210010.1111/j.1755-3768.2022.15469

8 

J Lorenzo-Morales NA Khan J Walochnik An update on Acanthamoeba keratitis: diagnosis, pathogenesis and treatmentParasite2015221010.1051/parasite/2015010

9 

H Alizadeh S Neelam M Hurt JY Niederkorn Role of Contact Lens Wear, Bacterial Flora, and Mannose-Induced Pathogenic Protease in the Pathogenesis of Amoebic KeratitisInfect Immun200573210618

10 

M Garate H Alizadeh S Neelam JY Niederkorn N Panjwani Oral Immunization with Acanthamoeba castellanii Mannose-Binding Protein Ameliorates Amoebic KeratitisInfect Immun2006741270324

11 

DW Clarke JY Niederkorn The pathophysiology of Acanthamoeba keratitisTrends Parasitol200622417580

12 

S Neelam JY Niederkorn Pathobiology and Immunobiology of Acanthamoeba Keratitis: Insights from Animal ModelsYale J Biol Med20179022618

13 

NJ Maycock R Jayaswal Update on Acanthamoeba keratitis: diagnosis, treatment, and outcomesCornea201635571320

14 

JY Niederkorn The biology of Acanthamoeba keratitisExp Eye Res202120210836510.1016/j.exer.2020.108365

15 

I Hasni J Andréani P Colson BL Scola Description of virulent factors and horizontal gene transfers of keratitis-associated amoeba Acanthamoeba triangularis by genome analysisPathogens202093217

16 

YC Hong WM Lee HH Kong HJ Jeong DI Chung Molecular cloning and characterization of a cDNA encoding a laminin-binding protein (AhLBP) from Acanthamoeba healyiExp Parasitol20041063-495102

17 

M Ren L Gao X Wu TLR4: the receptor bridging Acanthamoeba challenge and intracellular inflammatory responses in human corneal cell linesImmunol Cell Biol201088552936

18 

MJ Kim HJ Jo HJ Sohn HJ Shin FS Quan HH Kong Evaluating the Diagnostic Potential of Chorismate Mutase Poly-Clonal Peptide Antibody for the Acanthamoeba Keratitis in an Animal ModelPathogens2023124526

19 

MJ Kim AJ Ham AY Park HJ Sohn HJ Shin FS Quan Detection of Acanthamoeba from Acanthamoeba Keratitis Mouse Model Using Acanthamoeba-Specific Antibodies Microorganisms20221091711

20 

H Kang HJ Sohn A Park A Ham JH Lee YH Oh Establishment of an Acanthamoeba keratitis mouse model confirmed by amoebic DNA amplificationSci Rep20211111

21 

C Sharma A Thakur A Bhatia A Gupta S Khurana Acanthamoeba keratitis in a mouse model using a novel approachIndian J Med Microbiol20213945237

22 

A Suryawanshi Z Cao J F Sampson N Panjwani IL-17A-mediated protection against acanthamoeba keratitisJ Immunol2015194265063

23 

Z Ge Y Qing S Zicheng S Shiying Rapid and sensitive diagnosis of Acanthamoeba keratitis by loop-mediated isothermal amplificationClin Microbiol Infect2013191110428

24 

M Ren X Wu Evaluation of three different methods to establish animal models of Acanthamoeba keratitisYonsei Med J20105111217

25 

H Alizadeh T Tripathi M Abdi AD Smith Pathogenic strains of Acanthamoeba are recognized by TLR4 and initiated inflammatory responses in the corneaPLoS One201493e9237510.1371/journal.pone.0092375

26 

T Tripathi M Abdi H Alizadeh Role of phospholipase A2 (PLA2) inhibitors in attenuating apoptosis of the corneal epithelial cells and mitigation of Acanthamoeba keratitisExp Eye Res201311318291

27 

RT Kashiwabuchi FR Carvalho YA Khan DD Freitas AS Foronda FE Hirai Assessing efficacy of combined riboflavin and UV-A light (365 nm) treatment of Acanthamoeba trophozoitesInvest Ophthalmol Vis Sci2011521393338

28 

H Alizadeh S Neelam JY Niederkorn Effect of immunization with the mannose-induced Acanthamoeba protein and Acanthamoeba plasminogen activator in mitigating Acanthamoeba keratitisInvest Ophthalmol Vis Sci200748125597604

29 

DW Clarke H Alizadeh JY Niederkorn Intracorneal instillation of latex beads induces macrophage-dependent protection against Acanthamoeba keratitisInvest Ophthalmol Vis Sci20064711491725

30 

M Hurt S Neelam J Niederkorn H Alizadeh Pathogenic Acanthamoeba spp secrete a mannose-induced cytolytic protein that correlates with the ability to cause diseaseInfect Immun20037111624355

31 

M Hurt S Apte H Leher K Howard J Niederkorn H Alizadeh Exacerbation of Acanthamoeba keratitis in animals treated with anti-macrophage inflammatory protein 2 or antineutrophil antibodiesInfect Immun2001695298895

32 

K Mcclellan K Howard J Y Niederkorn H Alizadeh Effect of steroids on Acanthamoeba cysts and trophozoitesInvest Ophthalmol Vis Sci20014212288593

33 

H Leher F Zaragoza S Taherzadeh H Alizadeh JY Niederkorn Monoclonal IgA antibodies protect against Acanthamoeba keratitisExp Eye Res19996917584

34 

HF Leher H Alizadeh WM Taylor AS Shea RS Silvany FV Klink Role of mucosal IgA in the resistance to Acanthamoeba keratitisInvest Ophthalmol Vis Sci19983913266673

35 

FV Klink WM Taylor H Alizadeh MJ Jager NV Rooijen JY Niederkorn The role of macrophages in Acanthamoeba keratitisInvest Ophthalmol Vis Sci1996377127181

36 

FV Klink H Leher MJ Jager H Alizadeh W Taylor JY Niederkorn Systemic immune response to Acanthamoeba keratitis in the Chinese hamsterOcul Immunol Inflamm19975423544

37 

FV Klink H Alizadeh G L Stewart MS Pidherney RE Silvany Y He Characterization and pathogenic potential of a soil isolate and an ocular isolate of Acanthamoeba castellanii in relation to Acanthamoeba keratitisCurr Eye Res19921112120720

38 

HT Atalay BS Uysal F Sarzhanov S Usluca N Yeşilırmak MC Özmen Rose Bengal-mediated photodynamic antimicrobial treatment of Acanthamoeba keratitisCurr Eye Res20204510120510

39 

YD Pertiwi Y Chikama T Sueoka JA Ko Y Kiuchi M Onodera Efficacy of Photodynamic Anti-Microbial Chemotherapy for Acanthamoeba Keratitis In VivoLasers Surg Med2021535695702

40 

Á Ortillés P Goni E Rubio M Sierra E Gámez MT Fernández A rabbit model of Acanthamoeba keratitis: Use of infected soft contact lenses after corneal epithelium debridement with a diamond burrInvest Ophthalmol Vis Sci201758212187

41 

Y He JP Mcculley H Alizadeh M Pidherney J Mellon JE Ubelaker A pig model of Acanthamoeba keratitis: transmission via contaminated contact lensesInvest Ophthalmol Vis Sci199233112633

42 

ND Fernandes MV Caliari FM Oliveira ABC Neto IA Rodrigues C Furst Experimental keratitis induced in rat by Acanthamoeba from distinct morphological groups/genotypes: a histological and immunohistochemical evaluationParasitol Res20231225116775

43 

J Gueudry LL Goff P Compagnon S Lefevre E Colasse E Aknine Evaluation of voriconazole anti-Acanthamoeba polyphaga in vitro activity, rat cornea penetration and efficacy against experimental rat Acanthamoeba keratitisJ Antimicrob Chemother201873718958

44 

AO Costa C Furst LO Rocha C Cirelli CN Cardoso FS Neiva Molecular diagnosis of Acanthamoeba keratitis: evaluation in rat model and application in suspected human casesParasitol Res20171164133944

45 

ZA Polat J Walochnik A Obwaller A Vural A Dursun MK Arici Miltefosine and polyhexamethylene biguanide: a new drug combination for the treatment of Acanthamoeba keratitisClin Exp Ophthalmol20144221518

46 

H Mirjalali M Niyyati H Abedkhojasteh Z Babaei M Sharifdini M Rezaeian Pathogenic assays of Acanthamoeba belonging to the T4 genotypeIran J Parasitol2013845305

47 

ZA Polat A Vural Effect of combined chlorhexidine gluconate and neosporin on experimental keratitis with two pathogenic strains of AcanthamoebaParasitol Res20121105194550

48 

MY Ren XY Wu Toll-like receptor 4 signalling pathway activation in a rat model of Acanthamoeba KeratitisParasite Immunol20113312533

49 

ZA Polat S Ozcelik A Vural E Yıldız A Cetin Clinical and histologic evaluations of experimental Acanthamoeba keratitisParasitol Res2007101616215

50 

A Vural ZA Polat A Topalkara MI Toker H Erdogan MK Arici The effect of propolis in experimental Acanthamoeba keratitisClin Exp Ophthalmol200735874954

51 

DF Larkin DL Easty Experimental Acanthamoeba keratitis: I. Preliminary findingsBr J Ophthalmol19907495515

52 

YG He JY Niederkorn JP Mcculley GL Stewart DR Meyer R Silvany In vivo and in vitro collagenolytic activity of Acanthamoeba castellaniiInvest Ophthalmol Vis Sci19903111223540

53 

ME Ávila-Blanco SL Aguilera-Martínez J Ventura-Juarez J Pérez-Serrano E Casillas-Casillas LF Barba-Gallardo Effectiveness of Polyclonal Antibody Immunoconjugate Treatment with Propamidine Isethionate for Amoebic Keratitis in Golden HamstersJ Parasitol Res20232023371336810.1155/2023/3713368

54 

DW Clarke H Alizadeh JY Niederkorn Failure of Acanthamoeba castellanii to produce intraocular infectionsInvest Ophthalmol Vis Sci200546724728

55 

H Nakagawa N Koike T Ehara T Hattori A Narimatsu S Kumakura Corticosteroid eye drop instillation aggravates the development of Acanthamoeba keratitis in rabbit corneas inoculated with Acanthamoeba and bacteriaSci Rep2019911282110.1038/s41598-019-49128-7

56 

H Nakagawa T Hattori N Koike T Ehara A Narimatsu S Kumakura Number of bacteria and time of coincubation with bacteria required for the development of Acanthamoeba keratitisCornea20173633537

57 

X Feng W Zheng Y Wang D Zhao X Jiang S Lv A rabbit model of Acanthamoeba keratitis that better reflects the natural human infectionAnat Rec (Hoboken)20152988150917

58 

H Nakagawa T Hattori N Koike T Ehara K Fujita H Takahashi Investigation of the role of bacteria in the development of Acanthamoeba keratitisCornea20153410130815

59 

M Berra G Galperín G Boscaro J Zarate J Tau P Chiaradia Treatment of Acanthamoeba keratitis by corneal cross-linkingCornea20133221748

60 

NA Said AT Shoeir N Panjwani M Garate Z Cao Local and systemic humoral immune response during acute and chronic Acanthamoeba keratitis in rabbitsCurr Eye Res200429642939

61 

GK Zorzi RS Schuh VJ Maschio NT Brazil MB Rott HF Teixeira Box Behnken design of siRNA-loaded liposomes for the treatment of a murine model of ocular keratitis caused by AcanthamoebaColloids Surf B Biointerfaces201917372532

62 

M Matthaei H Meng I Bhutto Q Xu E Boelke J Hanes Systematic assessment of microneedle injection into the mouse corneaEur J Med Res20121711910.1186/2047-783X-17-19

63 

M Chojnacki A Philbrick T Scherzi N Pecora PM Dunman RAF Wozniak A novel, broad-spectrum antimicrobial combination for the treatment of Pseudomonas aeruginosa corneal infectionsAntimicrob Agents Chemother20196310e0077719

64 

MS Kwong DJ Evans M Ni BA Cowell SMJ Fleiszig Human Tear Fluid Protects against Pseudomonas aeruginosa Keratitis in a Murine Experimental ModelInfect Immun2007755232532

65 

P Saraswathi RW Beuerman Corneal Biofilms: From Planktonic to Microcolony Formation in an Experimental Keratitis Infection with Pseudomonas AeruginosaOcul Surf201513433145

66 

M Deichelbohrer MF Wu B Seitz D Hüttenberger MW Laschke HJ Foth Bacterial keratitis: Photodynamic inactivation reduced experimental inflammationExp Ther Med2017145450914

67 

LD Hazlett FB Kreindler RS Berk R Barrett Aging alters the phagocytic capability of inflammatory cells induced into corneaCurr Eye Res19909212938

68 

LD Hazlett MM Moon S Dawisha RS Berk Age alters ADPase positive dendritic (Langerhans) cell response to P. aeruginosa ocular challengeCurr Eye Res19865534355

69 

MF Wu M Deichelbohrer T Tschernig MW Laschke N Szentmáry D Hüttenberger Chlorin e6 mediated photodynamic inactivation for multidrug resistant Pseudomonas aeruginosa keratitis in mice in vivoSci Rep201774453710.1038/srep44537

70 

ME Marquart Animal Models of Bacterial KeratitisJ Biomed Biotechnol2011201168064210.1155/2011/680642

71 

JY Niederkorn JE Ubelaker JP Mcculley GL Stewart DR Meyer JA Mellon Susceptibility of corneas from various animal species to in vitro binding and invasion by Acanthamoeba castellaniiInvest Ophthalmol Vis Sci199233110412

72 

SNH Alizadeh HD Cavanagh Amoebicidal activities of alexidine against 3 pathogenic strains of acanthamoebaEye Contact Lens200935115

73 

S Hayes C Boote J Lewis J Sheppard M Abahussin AJ Quantock Comparative study of fibrillar collagen arrangement in the corneas of primates and other mammalsAnat Rec (Hoboken)200729012154250

74 

JT Henriksson AM Mcdermott JPG Bergmanson Dimensions and morphology of the cornea in three strains of miceInvest Ophthalmol Vis Sci2009508364854

75 

S Hayashi T Osawa K Tohyama Comparative observations on corneas, with special reference to Bowman's layer and Descemet's membrane in mammals and amphibiansJ Morphol2002254324758

76 

JV Jester A Budge S Fisher J Huang Corneal keratocytes: phenotypic and species differences in abundant protein expression and in vitro light-scatteringInvest Ophthalmol Vis Sci2005467236978

77 

JL Ojeda JA Ventosa S Piedra The three-dimensional microanatomy of the rabbit and human cornea. A chemical and mechanical microdissection-SEM approachJ Anat2001199556776

78 

JE Schechter DW Warren AK Mircheff A lacrimal gland is a lacrimal gland, but rodent's and rabbit's are not humanOcul Surf20108311134

79 

M Reichard M Hovakimyan A Wree A Meyer-Lindenberg I Nolte C Junghans R Guthoff O Stachs Comparative in vivo confocal microscopical study of the cornea anatomy of different laboratory animalsCurrent Eye Research20103512107280

80 

L Royle E Matthews A Corfield M Berry PM Rudd RA Dwek Glycan structures of ocular surface mucins in man, rabbit and dog display species differencesGlycoconj J200825876373



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

Article type

Review Article


Article page

495-503


Authors Details

Sumeeta Khurana*, Chayan Sharma


Article History

Received : 10-06-2023

Accepted : 17-08-2023


Article Metrics


View Article As

 


Downlaod Files